Construction method and application of cd155 gene humanized non-human animal
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO LTD
- Publication Date
- 2021-05-04
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of animal genetic engineering and genetic modification, and in particular relates to a method for constructing a CD155 genetically modified non-human animal model and its application in the field of biomedicine. Background technique
[0002] CD155, also known as PVS, HVED, NECL5, TAGE4 or Necl-5, is a Nectin-like type I transmembrane glycoprotein, which belongs to the PVR-related (PRR) family under the immunoglobulin superfamily, and is an adhesion that promotes cell binding Protein, which can bind to poliovirus (PV for short) and allow it to enter susceptible cells, so it is more commonly called PVR (Poliovirus Receptor, poliovirus receptor). CD155 is expressed in monocytes, macrophages, endothelial cells, epithelial cells, CD34+ thymocytes and neurons, but it is highly expressed in most tumor cells, including lung cancer, breast cancer, ovarian cancer and melanoma. Studies have shown that CD155 plays an important r...